Please Wait.....
Report
NA Hyaluronic Acid Market - Industry Trends and Forecast to 2030
Market Report I 2022-12-01 I 278 Pages I Data Bridge Market Research
The North America hyaluronic acid market is projected to register a substantial CAGR of 9.0% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
North America Hyaluronic Acid Market, By Grade (Cosmetic Grade and Pharmaceutical Grade), Type (Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronic Acid, and Sodium Hyaluronate), Application (Aesthetics, Osteoarthritis, Pharmaceutical API, Cosmetics, Ophthalmology, and Others), End User (Medical Spas and Beauty Centers, Dermatology Clinics, and Cosmetic Surgery Centers), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of North America hyaluronic acid market are:
- Increasing awareness towards anti-aging non-invasive surgeries and dermal fillers
- Growing development of hyaluronic acid-based products in the market
- Growing desire to improve one's appearance
- Growing popularity of non-surgical or minimally invasive cosmetic procedures
Market Players
The major companies dealing in the North America hyaluronic acid market are listed below:
- Fidia Farmaceutici S.p.A.
- AbbVie.
- Bloomage Biotechnology Co., Ltd.
- GALDERMA
- LG Chem
- Anika Therapeutics, Inc.
- Abbott
- Kewpie Corporation
- Merz North America, Inc.
- LABORATOIRES FILLMED
- Prollenium Medical Technologies.
- Contipro a.s.
- Lifecore Biomedical, Inc.
- Teoxane
- RIVER PHARMA s.r.l.
- Symatese
- Stanford Chemicals owned by Oceania International LLC,
- Bioiberica S.A.U.
- GENESIS pharmacy services
TABLE OF CONTENTS
1 INTRODUCTION 87
1.1 OBJECTIVES OF THE STUDY 87
1.2 MARKET DEFINITION 87
1.3 OVERVIEW OF THE NORTH AMERICA HYALURONIC ACID MARKET 87
1.4 CURRENCY AND PRICING 89
1.5 LIMITATIONS 89
1.6 MARKETS COVERED 89
2 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION 96
2.1 MARKETS COVERED 96
2.2 GEOGRAPHICAL SCOPE 97
2.3 YEARS CONSIDERED FOR THE STUDY 98
2.4 DBMR TRIPOD DATA VALIDATION MODEL 99
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 102
2.6 MULTIVARIATE MODELLING 103
2.7 GRADE SEGMENT LIFELINE CURVE 103
2.8 DBMR MARKET POSITION GRID 104
2.9 VENDOR SHARE ANALYSIS 106
2.10 MARKET END USER COVERAGE GRID 107
2.11 SECONDARY SOURCES 108
3 EXECUTIVE SUMMARY 109
4 PREMIUM INSIGHTS 112
4.1 PESTEL ANALYSIS 113
4.2 PORTER'S FIVE FORCES 114
4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES 115
4.4 INDUSTRY INSIGHTS 116
5 REGULATORY FRAMEWORK 118
5.1 EGULATORY SCENARIO IN THE U.S. 118
5.2 REGULATORY SCENARIO IN EUROPE 119
5.3 REGULATORY SCENARIO IN CHINA 119
5.4 REGULATORY SCENARIO IN AUSTRALIA 120
6 MARKET OVERVIEW 121
6.1 DRIVERS 123
6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS 123
6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS 123
6.1.3 RISE IN PRODUCT APPROVALS 124
6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES 124
6.2 RESTRAINTS 125
6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET 125
6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES 126
6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION 126
6.3 OPPORTUNITIES 127
6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS 127
6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS 127
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 128
6.3.4 INCREASING RESEARCH AND DEVELOPMENT 128
6.4 CHALLENGES 129
6.4.1 ESCALATING PRODUCT RECALL 129
6.4.2 LACK OF EXPERTISE 129
7 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE 130
7.1 OVERVIEW 131
7.2 COSMETIC GRADE 134
7.2.1 GENDER 134
7.2.1.1 FEMALE PRODUCTS 134
7.2.1.2 MEN'S PRODUCT 135
7.2.2 PRODUCT TYPE 135
7.2.2.1 SKIN CARE 135
7.2.2.2 MAKEUP 135
7.2.2.3 CLEANSING 135
7.2.2.4 HAIR CARE 135
7.2.2.5 OTHERS 135
7.2.3 PROCEDURE 136
7.2.3.1 WRINKLE REMOVAL 136
7.2.3.2 SKIN SMOOTHENING 136
7.2.3.3 FACE LIFT 136
7.2.3.4 LIP AUGMENTATION 136
7.2.3.5 CHIN AUGMENTATION 136
7.2.3.6 FAT INJECTION 137
7.2.3.7 FACE LINE CORRECTION 137
7.2.3.8 ACNE SCAR TREATMENT 137
7.2.3.9 LIP PLUM 137
7.2.3.10 EAR LOBE REJUVENATION 137
7.2.3.11 LIPOATROPHY TREATMENT 137
7.2.3.12 OTHERS 137
7.3 PHARMACEUTICAL GRADE 138
7.3.1 TYPE 138
7.3.1.1 MEDICAL GRADE HYALURONIC ACID 139
7.3.1.2 INJECTION GRADE HYALURONIC ACID 139
7.3.2 PRODUCT TYPE 139
7.3.2.1 TOPICAL PREPARATIONS 139
7.3.2.2 INTRA-ARTICULAR INJECTION 139
7.3.2.2.1 PREFILLED INJECTIONS 140
7.3.2.2.2 VIAL 140
7.3.2.3 EYE DROPS 140
7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS 140
7.3.2.5 OTHERS 140
8 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE 141
8.1 OVERVIEW 142
8.2 SODIUM HYALURONATE 145
8.2.1 MOLECULAR WEIGHT 146
8.2.1.1 HIGH MOLECULAR WEIGHT 146
8.2.1.2 LOW MOLECULAR WEIGHT 146
8.2.1.3 MEDIUM MOLECULAR WEIGHT 146
8.2.2 BY TYPE 146
8.2.2.1 COSMETIC GRADE 146
8.2.2.1.1 GENDER 147
8.2.2.1.1.1 FEMALE PRODUCTS 147
8.2.2.1.1.2 MEN'S PRODUCT 147
8.2.2.1.2 PRODUCT TYPE 147
8.2.2.1.2.1 SKIN CARE 147
8.2.2.1.2.2 MAKEUP 148
8.2.2.1.2.3 CLEANSING 148
8.2.2.1.2.4 HAIR CARE 148
8.2.2.1.2.5 OTHERS 148
8.2.2.2 PHARMACEUTICAL GRADE 148
8.2.2.2.1 TYPE 148
8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 148
8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID 148
8.2.2.2.2 PRODUCT TYPE 149
8.2.2.2.2.1 TOPICAL PREPARATIONS 149
8.2.2.2.2.2 INTRA-ARTICULAR INJECTION 149
8.2.2.2.2.2.1 PREFILLED INJECTIONS 149
8.2.2.2.2.2.2 VIAL 150
8.2.2.2.2.3 EYE DROPS 150
8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 150
8.2.2.2.2.5 OTHERS 150
8.3 HYDROLYZED HYALURONIC ACID 150
8.3.1 MOLECULAR WEIGHT 151
8.3.1.1 HIGH MOLECULAR WEIGHT 151
8.3.1.2 LOW MOLECULAR WEIGHT 151
8.3.1.3 MEDIUM MOLECULAR WEIGHT 151
8.3.2 BY TYPE 152
8.3.2.1 COSMETIC GRADE 152
8.3.2.1.1 GENDER 152
8.3.2.1.1.1 FEMALE PRODUCTS 152
8.3.2.1.1.2 MEN'S PRODUCT 152
8.3.2.1.2 PRODUCT TYPE 153
8.3.2.1.2.1 SKIN CARE 153
8.3.2.1.2.2 MAKEUP 153
8.3.2.1.2.3 CLEANSING 153
8.3.2.1.2.4 HAIR CARE 153
8.3.2.1.2.5 OTHERS 153
8.3.2.2 PHARMACEUTICAL GRADE 154
8.3.2.2.1 TYPE 154
8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 154
8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID 154
8.3.2.2.2 PRODUCT TYPE 155
8.3.2.2.2.1 TOPICAL PREPARATIONS 155
8.3.2.2.2.2 INTRA-ARTICULAR INJECTION 155
8.3.2.2.2.2.1 PREFILLED INJECTIONS 155
8.3.2.2.2.2.2 VIAL 156
8.3.2.2.2.3 EYE DROPS 156
8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 156
8.3.2.2.2.5 OTHERS 156
8.4 SODIUM ACETYLATED HYALURONIC ACID 157
8.4.1 MOLECULAR WEIGHT 158
8.4.1.1 HIGH MOLECULAR WEIGHT 158
8.4.1.2 LOW MOLECULAR WEIGHT 158
8.4.1.3 MEDIUM MOLECULAR WEIGHT 158
8.4.2 BY TYPE 158
8.4.2.1 COSMETIC GRADE 159
8.4.2.1.1 GENDER 159
8.4.2.1.1.1 FEMALE PRODUCTS 159
8.4.2.1.1.2 MEN'S PRODUCT 159
8.4.2.1.2 PRODUCT TYPE 159
8.4.2.1.2.1 SKIN CARE 160
8.4.2.1.2.2 MAKEUP 160
8.4.2.1.2.3 CLEANSING 160
8.4.2.1.2.4 HAIR CARE 160
8.4.2.1.2.5 OTHERS 160
8.4.2.2 PHARMACEUTICAL GRADE 160
8.4.2.2.1 TYPE 160
8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID 161
8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID 161
8.4.2.2.2 PRODUCT TYPE 161
8.4.2.2.2.1 TOPICAL PREPARATIONS 161
8.4.2.2.2.2 INTRA-ARTICULAR INJECTION 161
8.4.2.2.2.2.1 PREFILLED INJECTIONS 162
8.4.2.2.2.2.2 VIAL 162
8.4.2.2.2.3 EYE DROPS 162
8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS 162
8.4.2.2.2.5 OTHERS 162
9 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION 163
9.1 OVERVIEW 164
9.2 AESTHETICS 167
9.3 OSTEOARTHRITIS 167
9.4 COSMETICS 168
9.5 OPHTHALMOLOGY 169
9.6 PHARMACEUTICAL API 170
9.7 OTHERS 171
10 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER 172
10.1 OVERVIEW 173
10.2 DERMATOLOGY CLINICS 176
10.3 COSMETIC SURGERY CENTERS 176
10.4 MEDICAL SPAS AND BEAUTY CENTERS 177
10.5 OTHERS 178
11 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL 179
11.1 OVERVIEW 180
11.2 RETAIL SALES 183
11.2.1 RETAIL PHARMACY 184
11.2.2 HOSPITAL PHARMACY 184
11.2.3 ONLINE PHARMACY 184
11.3 DIRECT TENDER 184
12 NORTH AMERICA HYALURONIC ACID MARKET, BY REGION 185
12.1 NORTH AMERICA 186
12.1.1 U.S. 201
12.1.2 CANADA 212
12.1.3 MEXICO 223
13 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE 234
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 234
14 SWOT ANALYSIS 235
15 COMPANY PROFILE 236
15.1 FIDIA FARMACEUTICI S.P.A. (2022) 236
15.1.1 COMPANY SNAPSHOT 236
15.1.2 REVENUE ANALYSIS 236
15.1.3 COMPANY SHARE ANALYSIS 237
15.1.4 PRODUCT PORTFOLIO 237
15.1.5 RECENT DEVELOPMENT 237
15.2 ABBVIE INC. 238
15.2.1 COMPANY SNAPSHOT 238
15.2.2 REVENUE ANALYSIS 238
15.2.3 COMPANY SHARE ANALYSIS 239
15.2.4 PRODUCT PORTFOLIO 239
15.2.5 RECENT DEVELOPMENTS 239
15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED 240
15.3.1 COMPANY SNAPSHOT 240
15.3.2 COMPANY SHARE ANALYSIS 240
15.3.3 PRODUCT PORTFOLIO 241
15.3.4 RECENT DEVELOPMENTS 242
15.4 GALDERMA 243
15.4.1 COMPANY SNAPSHOT 243
15.4.2 COMPANY SHARE ANALYSIS 243
15.4.3 PRODUCT PORTFOLIO 244
15.4.4 RECENT DEVELOPMENTS 244
15.5 LG CHEM (2022) 245
15.5.1 COMPANY SNAPSHOT 245
15.5.2 REVENUE ANALYSIS 245
15.5.3 COMPANY SHARE ANALYSIS 246
15.5.4 PRODUCT PORTFOLIO 246
15.5.5 RECENT DEVELOPMENTS 246
15.6 ABBOTT (2022) 247
15.6.1 COMPANY SNAPSHOT 247
15.6.2 REVENUE ANALYSIS 247
15.6.3 PRODUCT PORTFOLIO 248
15.6.4 RECENT DEVELOPMENTS 248
15.7 ANIKA THERAPEUTICS, INC. 249
15.7.1 COMPANY SNAPSHOT 249
15.7.2 REVENUE ANALYSIS 249
15.7.3 COMPANY SHARE ANALYSIS 250
15.7.4 PRODUCT PORTFOLIO 250
15.7.5 RECENT DEVELOPMENTS 251
15.8 BIOSCIENCE GMBH 252
15.8.1 COMPANY SNAPSHOT 252
15.8.2 PRODUCT PORTFOLIO 252
15.8.3 RECENT DEVELOPMENT 252
15.9 BIOXIS PHARMACEUTICALS 253
15.9.1 COMPANY SNAPSHOT 253
15.9.2 PRODUCT PORTFOLIO 253
15.9.3 RECENT DEVELOPMENTS 253
15.10 BIOIBERICA S.A.U 254
15.10.1 COMPANY SNAPSHOT 254
15.10.2 PRODUCT PORTFOLIO 254
15.10.3 RECENT DEVELOPMENTS 255
15.11 BOHUS BIOTECH AB 256
15.11.1 COMPANY SNAPSHOT 256
15.11.2 PRODUCT PORTFOLIO 256
15.11.3 RECENT DEVELOPMENTS 256
15.12 BRICKELL MEN'S PRODUCTS 257
15.12.1 COMPANY SNAPSHOT 257
15.12.2 PRODUCT PORTFOLIO 257
15.12.3 RECENT DEVELOPMENT 257
15.13 CONTIPRO A.S. 258
15.13.1 COMPANY SNAPSHOT 258
15.13.2 PRODUCT PORTFOLIO 258
15.13.3 RECENT DEVELOPMENTS 258
15.14 FILLMED 259
15.14.1 COMPANY SNAPSHOT 259
15.14.2 PRODUCT PORTFOLIO 259
15.14.3 RECENT DEVELOPMENT 260
15.15 GENESIS 261
15.15.1 COMPANY SNAPSHOT 261
15.15.2 PRODUCT PORTFOLIO 261
15.15.3 RECENT DEVELOPMENT 261
15.16 HUONS 262
15.16.1 COMPANY SNAPSHOT 262
15.16.2 PRODUCT PORTFOLIO 262
15.16.3 RECENT DEVELOPMENTS 262
15.17 KEWPIE CORPORATION 263
15.17.1 COMPANY SNAPSHOT 263
15.17.2 PRODUCT PORTFOLIO 263
15.17.3 RECENT DEVELOPMENTS 263
15.18 LIFECORE BIOMEDICAL, INC.(2022) 264
15.18.1 COMPANY SNAPSHOT 264
15.18.2 REVENUE ANALYSIS 264
15.18.3 PRODUCT PORTFOLIO 265
15.18.4 RECENT DEVELOPMENTS 265
15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA) 266
15.19.1 COMPANY SNAPSHOT 266
15.19.2 PRODUCT PORTFOLIO 266
15.19.3 RECENT DEVELOPMENTS 266
15.20 PROLLENIUM MEDICAL TECHNOLOGIES 267
15.20.1 COMPANY SNAPSHOT 267
15.20.2 PRODUCT PORTFOLIO 267
15.20.3 RECENT DEVELOPMENTS 267
15.21 RIVER PHARMA S.R.L. 268
15.21.1 COMPANY SNAPSHOT 268
15.21.2 PRODUCT PORTFOLIO 268
15.21.3 RECENT DEVELOPMENT 268
15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD. 269
15.22.1 COMPANY SNAPSHOT 269
15.22.2 PRODUCT PORTFOLIO 269
15.22.3 RECENT DEVELOPMENTS 269
15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC, 270
15.23.1 COMPANY SNAPSHOT 270
15.23.2 PRODUCT PORTFOLIO 270
15.23.3 RECENT DEVELOPMENTS 270
15.24 SYMATESE 271
15.24.1 COMPANY SNAPSHOT 271
15.24.2 PRODUCT PORTFOLIO 271
15.24.3 RECENT DEVELOPMENTS 271
15.25 TEOXANE 272
15.25.1 COMPANY SNAPSHOT 272
15.25.2 PRODUCT PORTFOLIO 272
15.25.3 RECENT DEVELOPMENTS 272
15.26 VIRCHOW BIOTECH 273
15.26.1 COMPANY SNAPSHOT 273
15.26.2 PRODUCT PORTFOLIO 273
15.26.3 RECENT DEVELOPMENTS 273
16 QUESTIONNAIRE 274
17 RELATED REPORTS 278
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security